Skip to main content
OpenTrials
Completed

NCT Number: NCT05000073

Influence of Socio-aesthetic Care on the Quality of Life of Hemodialysis Patients

The report of the Epidemiological and Information Network in Nephrology counted 44,978 hemodialysis patients in France in 2017, with more than 93% of them attending 3 sessions per week.

This multi-weekly recourse to the healthcare system in the context of substitution treatment constantly reminds patients of their disease and has a strong impact on their quality of life.

The 2011 REIN quality of life report showed that the quality of life of patients with renal failure, particularly dialysis patients, is impaired, particularly in its physical and mental components. A recent comparative study (van Sandwijk et al., 2019) comparing hemodialysis patients with hematological cancer patients under chemotherapy supports these data.

The June 2013 report of the "Etats généraux du rein", an initiative of patient associations, called for the improvement of quality of life to be made a priority and for the possibility of using supportive care and complementary non-drug techniques to be proposed.

Socio-aesthetic care, defined "as the practice of aesthetic care for people who are suffering or vulnerable", has found its place in hospitals as a complementary discipline to medical care, particularly in oncology.

We believe that in order to improve the overall quality of life of hemodialysis patients, the quality of the experience of each session must be improved. In this perspective, the repetition of socio-aesthetic care performed during dialysis sessions could contribute to the overall improvement of the quality of life.

A national survey (Saghatchian et al., 2018) on the impact of socio-aesthetic care in oncology confirms the positive perception of this care among cancer patients. Two studies carried out in hemodialysis (Bullen et al., 2018; Unal & Balci Akpinar, 2016) using complementary techniques, such as acupuncture, massage, or foot reflexology, highlight an impact on sleep, fatigue and quality of life.

The experience of implementing socio-aesthetic care in our hemodialysis unit also leads us to believe that they positively influence the perception of the session, and therefore perhaps the quality of life measured with a validated scale, the KDQOL (Kidney Disease Quality Of Life).

Our research therefore focuses on the effectiveness of social and aesthetic care during hemodialysis sessions to improve the quality of life of the hemodialysis patient.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Kidney Insufficiencies Chronic Disease Disease Attributes Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Kidney Diseases Male Urogenital Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Renal Insufficiency Renal Insufficiency, Chronic Urogenital Diseases Urologic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Damien JOLLY

Reims, France

About this study

Many studies have been conducted on the overall quality of life of hemodialysis patients, but our original approach is to hypothesize that the course of each dialysis session, taken individually, can influence the overall quality of life of patients.

We hypothesize that the repetition of socio-aesthetic care as supportive care during the dialysis session would be a non-drug means to improve the quality of life of hemodialysis patients and to improve the experience of the dialysis session, the overall satisfaction of the session.

This is a randomized open clinical trial, monocentric, with two parallel arms, comparing a social and esthetic care procedure performed during a session by two certified aesthetics at the usual treatment.

The target population for this study will be individuals suffering from chronic renal failure who have been undergoing hemodialysis in the Reims University Hospital for at least one month and who will be randomly assigned to one of the two groups:

  • Experimental group with socio-aesthetic care: choice of the type of care (facial modeling, hand modeling or manicure) by the patient at the rate of one session per week for 4 weeks.
  • Control unit with standard support

we use several validated scales:

  • Assessment of the quality of life with the KDQOL
  • Assessment of anxiety and depression with the HADS anxiety and HADS depression scale
  • Analogous visual evaluation of overall satisfaction with the session

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years of age or older;
  • Suffering from chronic kidney failure
  • On hemodialysis for 1 month
  • Dialysed 3 times a week
  • In heavy center ;
  • fluent in French;
  • Benefiting from a social security system;
  • Agreeing to participate in the study exclusion criteria :
  • Having cognitive problems hindering the comprehension of the tool.
  • Under protection of justice (guardianship or curatorship).
  • Patients allergic to the care products used
  • Patients with additional precautions related to a high risk of cross-transmission such as emerging highly resistant bacteria, scabies, clostridium difficile, pulmonary tuberculosis.
  • Patients in withdrawal from other dialysis centers

Treatment and study plan

dialysis and socio-aesthetic care

Other

dialysis and socio-aesthetic care

dialysis

Other

dialysis

Primary outcomes

  1. Scale of quality of life (KDQoL)

    Time frame: Day 0

    Quality of life is assess by using KDQoL from 0 (worse quality of life) to 100 (better quality of life)

  2. Scale of quality of life (KDQoL)

    Time frame: At Month 1

    Quality of life is assess by using KDQoL from 0 (worse quality of life) to 100 (better quality of life)

Secondary outcomes

  1. Scale of anxiety and depression (HADS)

    Time frame: Day 0

    Anxiety and Depression are assess by using HADS scales from 0 (no anxiety or no depression) to 21 (anxiety or depression )

  2. Scale of anxiety and depression (HADS)

    Time frame: At Month 1

    Anxiety and Depression are assess by using HADS scales from 0 (no anxiety or no depression) to 21 (anxiety or depression )

Sponsors and collaborators

Lead sponsor

CHU de Reims

Other

Registry information

Acronym: SocioAesthetic

Important dates

Study start
2022
Primary completion
2024
Study completion
2024
First posted
Aug 11, 2021
Registry last updated
Feb 10, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.